AGAP2 and gastric cancer: ,6 High expression of AGAP2-AS1 has been identified in gastric cancer and non-small-cell lung cancer, suggesting that knockdown of AGAP2-AS1 leads to a decrease in cell proliferation and migration, along with the repression of invasion and tumorigenesis.7